A Th1-inducing adjuvant, MPL, enhances antibody profiles in experimental animals suggesting it has the potential to improve the efficacy of allergy vaccines. (Q43812891)
Jump to navigation
Jump to search
scientific article published in October 2001
Language | Label | Description | Also known as |
---|---|---|---|
English | A Th1-inducing adjuvant, MPL, enhances antibody profiles in experimental animals suggesting it has the potential to improve the efficacy of allergy vaccines. |
scientific article published in October 2001 |
Statements
A Th1-inducing adjuvant, MPL, enhances antibody profiles in experimental animals suggesting it has the potential to improve the efficacy of allergy vaccines (English)
A W Wheeler
1 October 2001